TY - JOUR T1 - The effect of strict lock down measures on Covid-19 seroprevalence rate and herd immunity JF - medRxiv DO - 10.1101/2020.06.06.20123919 SP - 2020.06.06.20123919 AU - Maher A. Sughayer AU - Asem Mansour AU - Abeer Al Nuirat AU - Lina Souan AU - Mohammad Ghanem AU - Mahmoud Siag Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/09/07/2020.06.06.20123919.abstract N2 - Background Covid-19 seroprevalence rates and serological tests are important tools in understanding the epidemiology of the disease and help in the fight against it. Seroprevalence rates vary according to the population studied and the test employed and they range from 0.133 to 25.7%. The purpose of this study is to assess the seroprevalence rate in a population of healthy blood donors living under strict lockdown measures in Jordan which has in total 144 confirmed cases per million population.Methods Left-over sera and plasma samples from 746 healthy blood donors were tested using a commercially available FDA approved kit having a sensitivity and specificity of 100% and 99.8% respectively. External positive controls were used for validation.Results More than 80% of the donors were men 18-63 year old and residing in the capital city of Jordan, Amman. All tested specimens were negative yielding a zero seroprevalence rate in this healthy blood donor population.Conclusion Strict lockdown measures effectively limit intracommunity spread of the infection, however at the cost of lack of any acquired community immunity. Additionally the use of highly specific test is recommended in low prevalence setting.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:King Hussein Cancer Center IRB approved the study under the number 20 KHCC 97.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall data are avialble in the manuscript ER -